Nicholas Saraceno, Editor

The purpose for the deal, the CDMO says, is to meet the demand for commercial mammalian contract manufacturing.

A multiple myeloma survivor shares his story, including how patient assistance made a positive impact.

Presentation discusses the evolution of the patient assistance landscape, while presenting ways to collaborate.

Presentation offers insight on this aforementioned model that assists retail and specialty-lite brands.

Fireside chat uncovers ways to leverage this technology in order to boost medication adherence, engagement, and outcomes.

Panel discusses PAN Foundation’s inaugural “State of Patient Access” report, and dives deep into patient challenges.

Conference’s opening session addresses the evolving landscape of healthcare coverage and accessibility.

This financial toxicity is quite prominent, but what can be done to remedy treatment costs?

Under the group purchasing agreement, the serialization business will be the sole provider of DSCSA services for Premier’s 4,300-plus hospital and health system network.

Steven H. Collis, who currently holds the position, will transition to executive chair of the board.

The Asia-Pacific location is expected to provide serialization solutions for counterfeit medication entering the pharma supply chain.

A qualitative study explores how these drugs are impacting these patients’ lives, while digging deeper into the possibility of deprescribing, with insight from primary care physicians.

The company’s twice-daily, branded ruxolitinib cream 1.5% presents a significant reduction in abscess and inflammatory nodule (AN) count for the treatment of Hurley stage 1 or 2 (mild-to-moderate) hidradenitis suppurativa.

A USC study discovers that an increasing share of both generic and brand-name meds are being excluded from approval.

With out-of-pocket healthcare costs resulting in financial issues for patients, a cross-sectional study closely examines whether they are linked to more premature deaths.

A proposed Senate bill is intended to protect citizens’ private health and genetic information.

The contributions consist of multiple investments that aim to boost pandemic preparedness and overall public health protection.

The CDMO’s multi-million-dollar expansion project features commercial manufacturing suites and peptide manufacturing plants.

The CDC urges healthcare providers to preserve their current supply.

The pTau217 antibody helps pinpoint pathological changes related to the disease.

Momentum from the previous two years will propel the sector into the rest of 2024, says AM Best analysis.

The purchase boosts the parties’ sterile liquid manufacturing capabilities.

A JAMA Network Open study dives into how the utilization of a digital patient portal changed during the COVID-19 pandemic, while also exploring ways that multimorbidity and socioeconomic disparities affected those statistics.

The offering reportedly helps avoid product quarantine.

A cohort study investigates a potential correlation between the stresses caused by Mother Nature and mental health.

IPX203—an oral formulation carbidopa/levodopa extended-release capsules —would expand Zambon’s neurology portfolio.

Rob Besse offers a breakdown of the third-party logistics (3PL) process, including lessons that these providers have learned coming out of the pandemic.

A Carrum Health/PWC report surveys benefit managers spanning various self-insured employers in an effort to determine ways to improve the cancer treatment experience, especially from a cost perspective.

An MDVIP study reports that 61% of people feel hassled by the current structure.

An investigation evaluates whether SNAP benefits can also influence hypertension patients’ lack of medication adherence.